Protalix Biotherapeutics Inc (PLX) — Long-term Investment Intensity

Latest as of June 2020: 7.0%

Protalix Biotherapeutics Inc (PLX) has a Long-term Investment Intensity of 7.0% as of June 2020. Long-term investments of $5.03 Million represent 7.0% of total assets of $71.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Protalix Biotherapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

7.0%
LT Investments / Total Assets

Long-term Investments

$5.03 Million
USD

Total Assets

$71.71 Million
USD

Country

USA
NYSE MKT

Annual Long-term Investment Intensity for Protalix Biotherapeutics Inc (None–None)

The table below presents the year-by-year Long-term Investment Intensity for Protalix Biotherapeutics Inc from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Protalix Biotherapeutics Inc total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points